Literature DB >> 1397206

In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

A S Sekhon1, A A Padhye, A K Garg.   

Abstract

Ten isolates of Penicillium marneffei and eight of Pythium insidiosum were tested for their in vitro sensitivity to amphotericin B, hamycin (a polyene heptaene), two water-soluble analogs of amphotericin B and hamycin, namely, JAI-Amb, and JAI-hamycin,5-fluorocytosine, fluconazole, itraconazole,ketoconazole and miconazole. Itraconazole manifested the strongest activity against all of the 10 isolates of P. marneffei and would be the drug of choice in the treatment of penicilliosis due to P. marneffei. The polyene antibiotics amphotericin B and hamycin and their water-soluble analogs showed no appreciable activity against P. insidiosum. Pytium insidiosum isolates were sensitive to fluconazole, ketoconazole, and miconazole. Miconazole exhibited the strongest in vitro activity against all of the 8 isolates of P. insidiosum, followed by ketoconazole.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1397206     DOI： 10.1007/bf00158578

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  19 in total

1.  Penicillium marneffei: another pathogen to consider in patients infected with human immunodeficiency virus.

Authors:  D N Tsang; P C Li; M S Tsui; Y T Lau; K F Ma; E K Yeoh
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

2.  Chronic lymphadenopathy caused by Penicillium marneffei: a condition mimicking tuberculous lymphadenopathy.

Authors:  W C Yuen; Y F Chan; S L Loke; W H Seto; G P Poon; K K Wong
Journal:  Br J Surg       Date:  1986-12       Impact factor: 6.939

3.  Infection caused by Penicillium marneffei: description of first natural infection in man.

Authors:  A F DiSalvo; A M Fickling; L Ajello
Journal:  Am J Clin Pathol       Date:  1973-08       Impact factor: 2.493

4.  [A case of disseminated Penicillium marneffei penicilliosis in a patient with acquired immunodeficiency syndrome].

Authors:  T Ancelle; J Dupouy-Camet; F Pujol; X Nassif; L Ferradini; L Choudat; C de Bievre; B Dupont; E Drouhet; J Lapierre
Journal:  Presse Med       Date:  1988-05-28       Impact factor: 1.228

5.  In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on man.

Authors:  A S Sekhon; A Funk
Journal:  J Antimicrob Chemother       Date:  1977-01       Impact factor: 5.790

Review 6.  Penicillium marneffei infection: an underdiagnosed disease?

Authors:  D N Tsang; J K Chan; Y T Lau; W Lim; C H Tse; N K Chan
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

7.  Imported penicilliosis marneffei in the United States: report of a second human infection.

Authors:  K B Pautler; A A Padhye; L Ajello
Journal:  Sabouraudia       Date:  1984

Review 8.  Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus.

Authors:  T E Peto; R Bull; P R Millard; D W Mackenzie; C K Campbell; M E Haines; R G Mitchell
Journal:  J Infect       Date:  1988-05       Impact factor: 6.072

Review 9.  Human pythiosis associated with thalassemia hemoglobinopathy syndrome.

Authors:  B Sathapatayavongs; P Leelachaikul; R Prachaktam; V Atichartakarn; S Sriphojanart; P Trairatvorakul; S Jirasiritham; S Nontasut; C Eurvilaichit; T Flegel
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

10.  Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum.

Authors:  Z L Deng; D H Connor
Journal:  Am J Clin Pathol       Date:  1985-09       Impact factor: 2.493
View more
  16 in total

1.  Combat-Related Pythium aphanidermatum Invasive Wound Infection: Case Report and Discussion of Utility of Molecular Diagnostics.

Authors:  Aaron R Farmer; Clinton K Murray; Ian R Driscoll; Brian L Wickes; Nathan Wiederhold; Deanna A Sutton; Carmita Sanders; Katrin Mende; Brent Enniss; James Feig; Anuradha Ganesan; Elizabeth A Rini; Todd J Vento
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

2.  In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.

Authors:  Borann Sar; Sambo Boy; Chantary Keo; Chan Chhaya Ngeth; Narom Prak; Mich Vann; Didier Monchy; Jean Louis Sarthou
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

4.  In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.

Authors:  Ayrton S Cavalheiro; Grazieli Maboni; Maria I de Azevedo; Juliana S Argenta; Daniela I B Pereira; Tatiana B Spader; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

5.  In vitro comparison of terbinafine and itraconazole against Penicillium marneffei.

Authors:  M R McGinnis; N G Nordoff; N S Ryder; G B Nunn
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

6.  Penicillium marneffei: types and drug susceptibility.

Authors:  P Imwidthaya; K Thipsuvan; A Chaiprasert; S Danchaivijitra; R Sutthent; J Jearanaisilavong
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

7.  New insights into the in vitro susceptibility of Pythium insidiosum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Maiara B Pilotto; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

8.  Pulmonary penicillosis marneffei: report of the first imported case in Canada.

Authors:  A S Sekhon; L Stein; A K Garg; W A Black; J D Glezos; C Wong
Journal:  Mycopathologia       Date:  1994-10       Impact factor: 2.574

9.  In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.

Authors:  A S Sekhon; A K Garg; A A Padhye; Z Hamir
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

10.  A masquerader? Paecilomyces must be distinguished from Penicillium in fungal keratitis: a report of two contrasting cases.

Authors:  Arsham Sheybani; Alexander T Nguyen; George Harocopos; Anthony J Lubniewski; Andrew J W Huang
Journal:  BMJ Case Rep       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.